Lv11
46 积分 2024-11-11 加入
Severe eosinophilic asthma in Chinese C‐BIOPRED asthma cohort
2天前
已完结
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator–controlled VOYAGE 2 trial
6天前
已完结
Depemokimab, the first ultra-long-acting anti-IL-5 monoclonal antibody for severe eosinophilic asthma
8天前
已完结
A Pragmatic Trial of Symptom-Based Inhaled Corticosteroid Use in African-American Children with Mild Asthma
22天前
已完结
Anti-cytokine biologics for asthma in adults
22天前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
22天前
已完结
FcRn: the neonatal Fc receptor comes of age
22天前
已完结
Structural characterization of a human Fc fragment engineered for extended serum half-life
22天前
已完结
Safety profile of guselkumab in treatment of patients with psoriasis and coexisting hepatitis B or C: A multicenter prospective cohort study
26天前
已完结
Early Treatment Response to Mepolizumab Predicts Clinical Remission in Severe Eosinophilic Asthma
1个月前
已完结
皖公网安备34019202002308
